Assisted Conception Unit, Guy's and St Thomas' Foundation Trust, London, SE1 9RT, UK.
Reprod Health. 2009 Dec 3;6:20. doi: 10.1186/1742-4755-6-20.
The success rate of IVF treatment is low. A recent systematic review and meta-analysis found that the outcome of IVF treatment could be improved in patients who have experienced recurrent implantation failure if an outpatient hysteroscopy (OH) is performed before starting the new treatment cycle. However, the trials were of variable quality, leading to a call for a large and high-quality randomised trial. This protocol describes a multi-centre randomised controlled trial to test the hypothesis that performing an OH prior to starting an IVF cycle improves the live birth rate of the subsequent IVF cycle in women who have experienced two to four failed IVF cycles.
Eligible and consenting women will be randomised to either OH or no OH using an internet based trial management programme that ensures allocation concealment and employs minimisation for important stratification variables including age, body mass index, basal follicle stimulating hormone level and number of previous failed IVF cycles. The primary outcome is live birth rate per IVF cycle started. Other outcomes include implantation, clinical pregnancy and miscarriage rates.The sample size for this study has been estimated as 758 participants with 379 participants in each arm. Interim analysis will be conducted by an independent Data Monitoring Committee (DMC), and final analysis will be by intention to treat. A favourable ethical opinion has been obtained (REC reference: 09/H0804/32).
[corrected] The trial has been assigned the following ISRCTN number: ISRCTN35859078.
体外受精 (IVF) 治疗的成功率较低。最近的一项系统评价和荟萃分析发现,如果在开始新的治疗周期之前对经历反复着床失败的患者进行门诊宫腔镜检查 (OH),可以提高 IVF 治疗的结局。然而,这些试验的质量存在差异,因此需要进行一项大型且高质量的随机试验。本方案描述了一项多中心随机对照试验,旨在检验以下假设:在开始 IVF 周期之前进行 OH 可提高经历过 2 至 4 次 IVF 周期失败的女性随后 IVF 周期的活产率。
合格且同意的女性将使用基于互联网的试验管理程序随机分配至 OH 组或非 OH 组,该程序确保分配隐藏,并采用最小化方法对重要分层变量(包括年龄、体重指数、基础卵泡刺激素水平和之前 IVF 周期失败次数)进行分层。主要结局是每个开始的 IVF 周期的活产率。其他结局包括着床率、临床妊娠率和流产率。本研究的样本量估计为 758 名参与者,每组 379 名参与者。中期分析将由独立的数据监测委员会 (DMC) 进行,最终分析将采用意向治疗原则。已获得有利的伦理意见(REC 参考号:09/H0804/32)。
该试验已被分配以下 ISRCTN 编号:ISRCTN35859078。